stem-cell-therapy

Explore Forever Labs's outlook on 2026 trends in regenerative medicine. Longevity has transitioned from biohacking to a mainstream standard of care. Discover breakthroughs in "bio-liquidity", MSC priming, and epigenetic resetting, alongside regulatory shifts in the United States empowering patients to own their biology.

New research highlights the critical role of insulin-like growth factor 1 receptor (IGF1R) in enhancing stem cell self-renewal and therapeutic potential. Understanding IGF1R signaling could significantly improve regenerative treatments, making stem cell preservation more valuable for future health needs.

Florida HB 1617 authorizes physicians to perform FDA-unapproved stem cell therapy with specific requirements for manufacturing practices, patient consent, and advertising disclosures. Effective July 1, 2025.